WHO ICTRP trial
A crossover comparison study on overactive bladder: vibegron versus mirabegron
JPRN-UMIN000035525 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000035525 |
|---|---|
| Public title | A crossover comparison study on overactive bladder: vibegron versus mirabegron |
| Scientific title | A crossover comparison study on overactive bladder: vibegron versus mirabegron - Comparison of two beta 3-adrenoreceptor agonist |
| Primary sponsor | Ibaraki Seinan Medical Center Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | overactive bladder |
| Interventions | Vibegron Mirabegron |
| Registration date | Nov 1, 2019 |
| Target size | 50 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: